A Perth clinical research company has been selected to undertake a trial of a vaccine to combat COVID-19.<\/p>\n
Linear Clinical Research announced it will conduct a human trial of the vaccine candidate, which is being developed to help the body produce antibodies to fight the coronavirus which causes COVID-19 disease.<\/p>\n
The vaccine candidate COVID-19 S-Trimer has been developed by China-based, global biotechnology company Clover Biopharmaceuticals.<\/p>\n
Phase 1 of the vaccine trial is planned to involve healthy adult and healthy elderly participants and the company is currently seeking volunteers to participate in the study within the next two months.<\/p>\n
Linear\u2019s Chief Executive Officer Jayden Rogers said if successful, a larger clinical trial involving thousands of people around the world would be conducted immediately.<\/p>\n
Mr Rogers said the COVID-19 S-Trimer vaccine trial was a major coup for WA and Australia.<\/p>\n
\u201cWA is in the unique position of working towards successfully suppressing the disease, so medical experts can dedicate resources to prevention.<\/p>\n
\u201cWe are fortunate to be one of the few countries in the world to still be offering functional clinical trial facilities because we do not have large volumes of COVID-19 cases as compared to other parts of the world,\u201d he said.<\/p>\n
Mr Rogers said Clover was one of the first companies to start developing a vaccine and started working on it in January this year.<\/p>\n
The company\u2019s access to early COVID-19 data and reagents made them one of the first companies to develop a vaccine which targets a protein that the virus needs to enter host cells.<\/p>\n
He said there were more than 60 candidate COVID-19 vaccines in development around the world, but only a few were entering early clinical trials in human volunteers.<\/p>\n","protected":false},"excerpt":{"rendered":"
A Perth clinical research company has been selected to undertake a trial of a vaccine to combat COVID-19. Linear Clinical Research announced it will conduct a human trial of the vaccine candidate, which is being developed to help the body produce antibodies to fight the coronavirus which causes COVID-19 disease. The vaccine candidate COVID-19 S-Trimer […]<\/p>\n","protected":false},"author":1,"featured_media":5204,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"pagelayer_contact_templates":[],"_pagelayer_content":"","footnotes":""},"categories":[19],"tags":[],"class_list":["post-6673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/posts\/6673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/comments?post=6673"}],"version-history":[{"count":0,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/posts\/6673\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/media?parent=6673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/categories?post=6673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/old-website.retprogram.org\/wahtn\/wp-json\/wp\/v2\/tags?post=6673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}